Iranian Red Crescent Medical Journal

Published by: Kowsar

Prediction of Biomarkers for Hepatocellular Carcinoma Through Microarray-Based DNA Methylation Analysis

Yan-Lan Zhang 1 , Zhong-Yue Han 2 , Xiu Pang 3 and Cheng Xu 4 , *
Authors Information
1 Department of Infectious Disease, People’s Hospital of Rizhao, Rizhao 276826, Shandong PR, China
2 Department of Gynecology, People’s Hospital of Rizhao, Rizhao 276826, Shandong PR, China
3 Digestive System Department, Ji Ning Hospitai of Tranditional Chinese Medicine, Jining 272000, Shandong PR, China
4 Department of Infectious Disease, People’s Hospital of Linyi, Linyi 276000, Shandong PR, China
Article information
  • Iranian Red Crescent Medical Journal: January 2018, 20 (1); e14873
  • Published Online: January 7, 2018
  • Article Type: Research Article
  • Received: June 8, 2017
  • Revised: July 19, 2017
  • Accepted: October 21, 2017
  • DOI: 10.5812/ircmj.14873

To Cite: Zhang Y, Han Z, Pang X, Xu C. Prediction of Biomarkers for Hepatocellular Carcinoma Through Microarray-Based DNA Methylation Analysis, Iran Red Crescent Med J. 2018 ; 20(1):e14873. doi: 10.5812/ircmj.14873.

Copyright © 2018, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
5. Conclusion
  • 1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-76. doi: 10.1053/j.gastro.2007.04.061. [PubMed: 17570226].
  • 2. Wang YC, Wei LJ, Liu JT, Li SX, Wang QS. Comparison of Cancer Incidence between China and the USA. Cancer Biol Med. 2012;9(2):128-32. doi: 10.3969/j.issn.2095-3941.2012.02.009. [PubMed: 23691468].
  • 3. Kudo M. Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol. 2004;39(3):205-14. doi: 10.1007/s00535-003-1280-y. [PubMed: 15064996].
  • 4. Brudvik KW, Vauthey JN. Peeling-off technique or bile duct resection of tumor thrombus in hepatocellular carcinoma: does future liver-directed treatment justify less extensive surgery?. Ann Surg. 2015;261(5). e126. doi: 10.1097/SLA.0000000000001210. [PubMed: 25775077].
  • 5. McCormack L, Petrowsky H, Clavien PA. Surgical therapy of hepatocellular carcinoma. Europ J Gastroenterol Hepatol. 2005;17(5):497-503.
  • 6. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology. 2011;140(5):1501-12 e2. doi: 10.1053/j.gastro.2011.02.006. [PubMed: 21320499].
  • 7. Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, et al. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology. 2013;144(5):1024-30. doi: 10.1053/j.gastro.2013.01.021. [PubMed: 23333348].
  • 8. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 2002;62(10):2890-6. [PubMed: 12019169].
  • 9. Liu F, Zhou D, Zhang Q, Wang B. Comments on the article of Bu, et al entitled "P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis". Int J Clin Exp Pathol. 2015;8(3):3384-5. [PubMed: 26045875].
  • 10. Ganguly A, Shields CL. Differential gene expression profile of retinoblastoma compared to normal retina. Mol Vis. 2010;16:1292-303. [PubMed: 20664703].
  • 11. Reis AH, Vargas FR, Lemos B. More epigenetic hits than meets the eye: microRNAs and genes associated with the tumorigenesis of retinoblastoma. Front Genet. 2012;3:284. doi: 10.3389/fgene.2012.00284. [PubMed: 23233862].
  • 12. Portales-Casamar E, Lussier AA, Jones MJ, MacIsaac JL, Edgar RD, Mah SM, et al. DNA methylation signature of human fetal alcohol spectrum disorder. Epigenetics Chromatin. 2016;9:25. doi: 10.1186/s13072-016-0074-4. [PubMed: 27358653].
  • 13. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28(10):1057-68. doi: 10.1038/nbt.1685. [PubMed: 20944598].
  • 14. Zhao Y, Sun J, Zhang H, Guo S, Gu J, Wang W, et al. High-frequency aberrantly methylated targets in pancreatic adenocarcinoma identified via global DNA methylation analysis using methylCap-seq. Clin Epigenetics. 2014;6(1):18. doi: 10.1186/1868-7083-6-18. [PubMed: 25276247].
  • 15. Jiang F, Todd NW, Li R, Zhang H, Fang H, Stass SA. A panel of sputum-based genomic marker for early detection of lung cancer. Cancer Prev Res (Phila). 2010;3(12):1571-8. doi: 10.1158/1940-6207.CAPR-10-0128. [PubMed: 20864512].
  • 16. Zhu J, Yao X. Use of DNA methylation for cancer detection: promises and challenges. Int J Biochem Cell Biol. 2009;41(1):147-54. doi: 10.1016/j.biocel.2008.09.003. [PubMed: 18834953].
  • 17. Lambert MP. Aberrant DNA methylation of imprinted loci in hepatocellular carcinoma and after in vitro exposure to common risk factors. Clinic Epigenet. 2015;7(1):15.
  • 18. Yamada N, Yasui K, Dohi O, Gen Y, Tomie A, Kitaichi T, et al. Genome-wide DNA methylation analysis in hepatocellular carcinoma. Oncol Rep. 2016;35(4):2228-36. doi: 10.3892/or.2016.4619. [PubMed: 26883180].
  • 19. Villanueva A, Hoshida Y, Toffanin S, Lachenmayer A, Alsinet C, Savic R, et al. New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin Cancer Res. 2010;16(19):4688-94. doi: 10.1158/1078-0432.CCR-09-1811. [PubMed: 20713493].
  • 20. Mah WC, Thurnherr T, Chow PK, Chung AY, Ooi LL, Toh HC, et al. Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis. PLoS One. 2014;9(8). e104158. doi: 10.1371/journal.pone.0104158. [PubMed: 25093504].
  • 21. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587. doi: 10.1186/1471-2105-11-587. [PubMed: 21118553].
  • 22. Wu P, Farrell WE, Haworth KE, Emes RD, Kitchen MO, Glossop JR, et al. Maternal genome-wide DNA methylation profiling in gestational diabetes shows distinctive disease-associated changes relative to matched healthy pregnancies. Epigenet. 2016;(just-accepted):00.
  • 23. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013;29(2):189-96. doi: 10.1093/bioinformatics/bts680. [PubMed: 23175756].
  • 24. Fryer AA, Emes RD, Ismail KM, Haworth KE, Mein C, Carroll WD, et al. Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma homocysteine and birth weight in humans. Epigenetics. 2011;6(1):86-94. doi: 10.4161/epi.6.1.13392. [PubMed: 20864804].
  • 25. Glossop JR, Nixon NB, Emes RD, Haworth KE, Packham JC, Dawes PT, et al. Epigenome-wide profiling identifies significant differences in DNA methylation between matched-pairs of T- and B-lymphocytes from healthy individuals. Epigenetics. 2013;8(11):1188-97. doi: 10.4161/epi.26265. [PubMed: 24005183].
  • 26. Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, Laird PW, et al. Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns. Hum Mol Genet. 2009;18(24):4808-17. doi: 10.1093/hmg/ddp445. [PubMed: 19776032].
  • 27. Suzuki R, Shimodaira H. Hierarchical Clustering with p-Values via Multiscale Bootstrap Resampling. R Packag Ver. 2009:1.2-1.
  • 28. Deu-Pons J, Schroeder MP, Lopez-Bigas N. jHeatmap: an interactive heatmap viewer for the web. Bioinformatics. 2014;30(12):1757-8. doi: 10.1093/bioinformatics/btu094. [PubMed: 24567544].
  • 29. Kumatani S, Itoh T, Motohashi Y, Umezu K, Takatsuka M, editors. Time-Varying Data Visualization Using Clustered Heatmap and Dual Scatterplots. Information Visualisation (IV), 2016 20th International Conference. 2016. IEEE; 2016. p. 63-8.
  • 30. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Natur Potocol. 2008;4(1):44.
  • 31. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1-2):279-84.
  • 32. Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol. 2012;8(2). e1002375. doi: 10.1371/journal.pcbi.1002375. [PubMed: 22383865].
  • 33. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, et al. KEGG for linking genomes to life and the environment. Nucleic Acid Res. 2007;36(suppl_1):D480-4.
  • 34. Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63(5):844-55. doi: 10.1136/gutjnl-2013-306627. [PubMed: 24531850].
  • 35. Zhong JH, Xiang BD, Gong WF, Ke Y, Mo QG, Ma L, et al. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. PLoS One. 2013;8(7). e68193. doi: 10.1371/journal.pone.0068193. [PubMed: 23874536].
  • 36. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406(6797):782-7. doi: 10.1038/35021228. [PubMed: 10963608].
  • 37. Brinkhoff B, Ostroumov D, Heemcke J, Woller N, Gurlevik E, Manns MP, et al. Microsphere priming facilitates induction of potent therapeutic T-cell immune responses against autochthonous liver cancers. Eur J Immunol. 2014;44(4):1213-24. doi: 10.1002/eji.201343794. [PubMed: 24338782].
  • 38. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007;25(18):2586-93. doi: 10.1200/JCO.2006.09.4565. [PubMed: 17577038].
  • 39. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell. 2006;10(2):99-111. doi: 10.1016/j.ccr.2006.06.016. [PubMed: 16904609].
  • 40. Butler JE, Kadonaga JT. The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev. 2002;16(20):2583-92. doi: 10.1101/gad.1026202. [PubMed: 12381658].
  • 41. Tang H, Delgermaa L, Huang F, Oishi N, Liu L, He F, et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol. 2005;79(9):5548-56.
  • 42. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56(6):1384-91. doi: 10.1016/j.jhep.2011.10.027. [PubMed: 22326465].
  • 43. Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene. 2007;26(6):851-8. doi: 10.1038/sj.onc.1209846. [PubMed: 16878148].
  • 44. Watanabe M, Maemura K, Oki K, Shiraishi N, Shibayama Y, Katsu K. Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells. Histol Histopathol. 2006;21(10):1135-41. doi: 10.14670/HH-21.1135. [PubMed: 16835836].
  • 45. Urrego D, Tomczak AP, Zahed F, Stuhmer W, Pardo LA. Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci. 2014;369(1638):20130094. doi: 10.1098/rstb.2013.0094. [PubMed: 24493742].
  • 46. Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, et al. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int. 2012;32(5):752-60. doi: 10.1111/j.1478-3231.2011.02750.x. [PubMed: 22276989].
  • 47. Mah WC, Lee CG. DNA methylation: potential biomarker in Hepatocellular Carcinoma. Biomark Res. 2014;2(1):5. doi: 10.1186/2050-7771-2-5. [PubMed: 24635883].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments